Clinical Trials Browser

Phase 2 × OTHER × Olfaction Disorders × Clear all

NCT00316563 2010-02-09

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

Phase 2 Completed

Anorexia, Olfaction Disorders, Neoplasms, Taste Disorders